Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01923623
Other study ID # Huggi123
Secondary ID
Status Withdrawn
Phase Phase 4
First received August 13, 2013
Last updated April 2, 2017
Start date July 1, 2013
Est. completion date July 31, 2013

Study information

Verified date April 2017
Source Herlev Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical, randomized, and controlled study will provide valuable scientific evidence regarding the effect of adding peripheral nerve blockades to general anaesthesia during ankle surgery. In particular, the investigators want to determine if the need for postoperative opioids will be reduced and whether this will lead to shorter admission to recovery room and fewer instances of side effects such as postoperative nausea and vomiting. In addition, the investigators will determine whether the functional outcome is improved i.e. faster and more successful rehabilitation. This would have profound benefits not only to the individual patient but also to society by reducing expenses during admission, the cost of sick leave etc.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 31, 2013
Est. primary completion date July 1, 2013
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age >18 years

- Patients in need of anaesthesia for operative fixation of ankle fractures.

- American Society of Anesthesiologists (ASA) score 1-3.

- BMI > 18 og < 35.

- Oral and written consent

Exclusion Criteria:

- Weight < 50kg

- Allergy towards drugs used in the study

- Patients for re-operation

- Other fracture at the same time

- Pregnancy

- Daily use of opioids within two weeks before operation

- Infection near the application site

- Patients in need of dialysis

- Patients with neuropathy in lower extremities

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ropivacaine block


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Herlev Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Use of Morphine 24 hours
Secondary Functional rehabilitation outcome American Orthopaedic Foot and Ankle Society (AOFAS) score 10-14 weeks